Trade Mark Journal No.2021/053 31 December 2021

UK00003717454 3 November 2021 (1,5,42,44)

Image for mark UK00003717454 mi-LUNG
International priority date claimed: 16 June 2021 (European Union Intellectual Property Office (EUIPO)) (018493914)
Class 1
Chemicals for use in industry or science; reagents for use in industry or science; test or collection kits for use in industry or science; sampling kits for use in industry or science; diagnostic kits for use in industry or science.
Class 5
Pharmaceutical products; pharmaceuticals; reagents for diagnostic, pharmaceutical, or medical use; diagnostics for medical or pharmaceutical purposes; medical preparations; therapeutic preparations; diagnostic preparations; preparations for therapeutic, diagnostic, pharmaceutical, or medical purposes; sampling kits; test kits for diagnostic, pharmaceutical, or medical purposes, in particular mainly consisting of chemical reagents [included in this class]; kits comprising reagents for diagnostic, pharmaceutical, or medical purposes; kits comprising agents for therapeutic purposes.
Class 42
Scientific and technological services; scientific analysis and research services in the medical, biotechnological and/or diagnostic fields; industrial analysis and research services in the medical, biotechnological and/or diagnostic fields; research and related development of pharmaceutical products and substances; development of new medicines; scientific research services for diagnostic purposes;   consultancy services for scientific, laboratory and research purposes; contract research in the field of pharmacological and clinical development of medicinal products; data analysis for scientific and technical purposes, namely analysis of data and clinical trials; preparing scientific opinions in the form of expert reports, analysis of experimental data, or scientific summaries in the medical, biotechnological and/or diagnostic fields.
Class 44
Medical and veterinary services; health care for humans and animals; medical and veterinary diagnostic services in pre-clinical and clinical areas; diagnostic services for humans and animals; services of a diagnostic laboratory; medical analysis services relating to the treatment of humans and animals; diagnostic services for determining diseases or disorders, monitoring diseases or disorders, or determining the therapeutic success of diseases or disorders; non-invasive diagnostics; blood- or biopsy-based diagnostics; personalized medicine or diagnostics; diagnostic health monitoring or health surveillance.

Hummingbird Diagnostics GmbH

Representative: Bromhead Johnson LLP